Gonococcal resistance: are cephalosporins next?

Abstract

The development of resistance to multiple antibiotics has limited treatment options for gonorrhea in many countries. Currently, the Centers for Disease Control and Prevention only recommend cephalosporin antibiotics for treatment of uncomplicated gonorrhea. Although the cephalosporins remain effective, the demonstrated ability of Neisseria gonorrhoeae to develop resistance has raised concerns about the possibility of multidrug-resistant N. gonorrhoeae strains, which include cephalosporin resistance. This article provides a review of global trends in cephalosporin susceptibility among gonococcal isolates, recent findings that deepen our understanding of genetic mechanisms of resistance, and the public health and clinical implications of the potential emergence of cephalosporin-resistant gonorrhea.

DOI: 10.1007/s11908-011-0169-9

Statistics

02040602011201220132014201520162017
Citations per Year

86 Citations

Semantic Scholar estimates that this publication has 86 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Kirkcaldy2011GonococcalRA, title={Gonococcal resistance: are cephalosporins next?}, author={Robert D . Kirkcaldy and Ronald Campbell Ballard and Deborah Dowell}, journal={Current infectious disease reports}, year={2011}, volume={13 2}, pages={196-204} }